These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 39083604)

  • 21. Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2.
    Afkhami S; D'Agostino MR; Zhang A; Stacey HD; Marzok A; Kang A; Singh R; Bavananthasivam J; Ye G; Luo X; Wang F; Ang JC; Zganiacz A; Sankar U; Kazhdan N; Koenig JFE; Phelps A; Gameiro SF; Tang S; Jordana M; Wan Y; Mossman KL; Jeyanathan M; Gillgrass A; Medina MFC; Smaill F; Lichty BD; Miller MS; Xing Z
    Cell; 2022 Mar; 185(5):896-915.e19. PubMed ID: 35180381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peritoneal Administration of a Subunit Vaccine Encapsulated in a Nanodelivery System Not Only Augments Systemic Responses against SARS-CoV-2 but Also Stimulates Responses in the Respiratory Tract.
    Jearanaiwitayakul T; Apichirapokey S; Chawengkirttikul R; Limthongkul J; Seesen M; Jakaew P; Trisiriwanich S; Sapsutthipas S; Sunintaboon P; Ubol S
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challenge.
    Lien CE; Lin YJ; Chen C; Lian WC; Kuo TY; Campbell JD; Traquina P; Lin MY; Liu LT; Chuang YS; Ko HY; Liao CC; Chen YH; Jan JT; Ma HH; Sun CP; Lin YS; Wu PY; Wang YC; Tao MH; Lin YL
    Sci Rep; 2021 Apr; 11(1):8761. PubMed ID: 33888840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters.
    Frantz PN; Barinov A; Ruffié C; Combredet C; Najburg V; de Melo GD; Larrous F; Kergoat L; Teeravechyan S; Jongkaewwattana A; Billon-Denis E; Tournier JN; Prot M; Levillayer L; Conquet L; Montagutelli X; Tichit M; Hardy D; Fernandes P; Strick-Marchand H; Di Santo J; Simon-Lorière E; Bourhy H; Tangy F
    Nat Commun; 2021 Nov; 12(1):6277. PubMed ID: 34725327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Newcastle Disease Virus (NDV)-based vaccine candidate against SARS-CoV-2 Omicron by intranasal immunization.
    Zhang QY; Zhang HQ; Zhang YN; Zhang ZR; Li XD; Hao MC; Zhang Y; Li JQ; Hu YY; Chen XL; Wang J; Shi YJ; Deng CL; Chen JJ; Ye HQ; Zhang B
    Antiviral Res; 2023 Dec; 220():105757. PubMed ID: 37984567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models.
    Ku MW; Bourgine M; Authié P; Lopez J; Nemirov K; Moncoq F; Noirat A; Vesin B; Nevo F; Blanc C; Souque P; Tabbal H; Simon E; Hardy D; Le Dudal M; Guinet F; Fiette L; Mouquet H; Anna F; Martin A; Escriou N; Majlessi L; Charneau P
    Cell Host Microbe; 2021 Feb; 29(2):236-249.e6. PubMed ID: 33357418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Three SARS-CoV-2 spike protein variants delivered intranasally by measles and mumps vaccines are broadly protective.
    Zhang Y; Chamblee M; Xu J; Qu P; Shamseldin MM; Yoo SJ; Misny J; Thongpan I; Kc M; Hall JM; Gupta YA; Evans JP; Lu M; Ye C; Hsu CC; Liang X; Martinez-Sobrido L; Yount JS; Boyaka PN; Liu SL; Dubey P; Peeples ME; Li J
    Nat Commun; 2024 Jul; 15(1):5589. PubMed ID: 38961063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A single-dose intranasal live-attenuated codon deoptimized vaccine provides broad protection against SARS-CoV-2 and its variants.
    Liu X; Ng WH; Zusinaite E; Freitas J; Taylor A; Yerragunta V; Aavula SM; Gorriparthi S; Ponsekaran S; Bonda RL; Mani P; Nimmagadda SV; Wang S; Lello LS; Zaid A; Dua U; Taft-Benz SA; Anderson E; Baxter VK; Sarkar S; Ling ZL; Ashhurst TM; Cheng SMS; Pattnaik P; Kanakasapapathy AK; Baric RS; Burt FJ; Peiris M; Heise MT; King NJC; Merits A; Lingala R; Mahalingam S
    Nat Commun; 2024 Aug; 15(1):7225. PubMed ID: 39187479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intranasal Delivery of MVA Vector Vaccine Induces Effective Pulmonary Immunity Against SARS-CoV-2 in Rodents.
    Bošnjak B; Odak I; Barros-Martins J; Sandrock I; Hammerschmidt SI; Permanyer M; Patzer GE; Greorgiev H; Gutierrez Jauregui R; Tscherne A; Schwarz JH; Kalodimou G; Ssebyatika G; Ciurkiewicz M; Willenzon S; Bubke A; Ristenpart J; Ritter C; Tuchel T; Meyer Zu Natrup C; Shin DL; Clever S; Limpinsel L; Baumgärtner W; Krey T; Volz A; Sutter G; Förster R
    Front Immunol; 2021; 12():772240. PubMed ID: 34858430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2.
    Hassan AO; Kafai NM; Dmitriev IP; Fox JM; Smith BK; Harvey IB; Chen RE; Winkler ES; Wessel AW; Case JB; Kashentseva E; McCune BT; Bailey AL; Zhao H; VanBlargan LA; Dai YN; Ma M; Adams LJ; Shrihari S; Danis JE; Gralinski LE; Hou YJ; Schäfer A; Kim AS; Keeler SP; Weiskopf D; Baric RS; Holtzman MJ; Fremont DH; Curiel DT; Diamond MS
    Cell; 2020 Oct; 183(1):169-184.e13. PubMed ID: 32931734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishment of human post-vaccination SARS-CoV-2 standard reference sera.
    Xiang J; Katz L; Winokur PL; Chaudhary A; Digmann B; Bradford R; Rashid S; Ghosh S; Robertson A; Menetski J; Xu M; Gao P; Chen CZ; Lee T; Poelaert B; Eastman RT; Hall MD; Stapleton JT
    J Immunol Methods; 2024 Jul; 530():113698. PubMed ID: 38823574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multivalent nanoparticle-based vaccines protect hamsters against SARS-CoV-2 after a single immunization.
    Chiba S; Frey SJ; Halfmann PJ; Kuroda M; Maemura T; Yang JE; Wright ER; Kawaoka Y; Kane RS
    Commun Biol; 2021 May; 4(1):597. PubMed ID: 34011948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity of intranasal vaccine based on SARS-CoV-2 spike protein during primary and booster immunizations in mice.
    Yang H; Xie Y; Li S; Bao C; Wang J; Li C; Nie J; Quan Y
    Hum Vaccin Immunother; 2024 Dec; 20(1):2364519. PubMed ID: 38880868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamsters.
    Kulkarni R; Chen WC; Lee Y; Kao CF; Hu SL; Ma HH; Jan JT; Liao CC; Liang JJ; Ko HY; Sun CP; Lin YS; Wang YC; Wei SC; Lin YL; Ma C; Chao YC; Chou YC; Chang W
    PLoS One; 2021; 16(9):e0257191. PubMed ID: 34499677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease.
    Deschambault Y; Lynch J; Warner B; Tierney K; Huynh D; Vendramelli R; Tailor N; Frost K; Sajesh B; LeBlanc K; Layne C; Lin L; Tamming L; Beniac D; Booth S; Carpenter M; Safronetz D; Li X; Kobasa D; Cao J
    J Virol; 2022 May; 96(9):e0038922. PubMed ID: 35412347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A single intranasal or intramuscular immunization with chimpanzee adenovirus vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters.
    Bricker TL; Darling TL; Hassan AO; Harastani HH; Soung A; Jiang X; Dai YN; Zhao H; Adams LJ; Holtzman MJ; Bailey AL; Case JB; Fremont DH; Klein R; Diamond MS; Boon ACM
    bioRxiv; 2020 Dec; ():. PubMed ID: 33299991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection.
    Liu R; Americo JL; Cotter CA; Earl PL; Erez N; Peng C; Moss B
    Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33688035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inactivated rabies virus vectored SARS-CoV-2 vaccine prevents disease in a Syrian hamster model.
    Kurup D; Malherbe DC; Wirblich C; Lambert R; Ronk AJ; Zabihi Diba L; Bukreyev A; Schnell MJ
    PLoS Pathog; 2021 Mar; 17(3):e1009383. PubMed ID: 33765062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and Immunogenicity Analysis of a Newcastle Disease Virus (NDV-HXP-S) Expressing the Spike Protein of SARS-CoV-2 in Sprague Dawley Rats.
    Tcheou J; Raskin A; Singh G; Kawabata H; Bielak D; Sun W; González-Domínguez I; Sather DN; García-Sastre A; Palese P; Krammer F; Carreño JM
    Front Immunol; 2021; 12():791764. PubMed ID: 34868082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intranasal inoculation of an MVA-based vaccine induces IgA and protects the respiratory tract of hACE2 mice from SARS-CoV-2 infection.
    Americo JL; Cotter CA; Earl PL; Liu R; Moss B
    Proc Natl Acad Sci U S A; 2022 Jun; 119(24):e2202069119. PubMed ID: 35679343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.